Marker Therapeutics to Present Four Posters on its T Cell-Based Immunotherapies at the 2022 International Society for Cell & Gene Therapy Annual Meeting
Stock Information for Marker Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.